These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 26607475)

  • 1. The Toolbox for Modified Aptamers.
    Lapa SA; Chudinov AV; Timofeev EN
    Mol Biotechnol; 2016 Feb; 58(2):79-92. PubMed ID: 26607475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids.
    Meek KN; Rangel AE; Heemstra JM
    Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2',4'-BNA/LNA aptamers: CE-SELEX using a DNA-based library of full-length 2'-O,4'-C-methylene-bridged/linked bicyclic ribonucleotides.
    Kasahara Y; Irisawa Y; Ozaki H; Obika S; Kuwahara M
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1288-92. PubMed ID: 23374873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic recognition of 2'-modified ribonucleoside 5'-triphosphates: towards the evolution of versatile aptamers.
    Lauridsen LH; Rothnagel JA; Veedu RN
    Chembiochem; 2012 Jan; 13(1):19-25. PubMed ID: 22162282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrogating Aptamer Chemical Space Through Modified Nucleotide Substitution Facilitated by Enzymatic DNA Synthesis.
    Niogret G; Bouvier-Müller A; Figazzolo C; Joyce JM; Bonhomme F; England P; Mayboroda O; Pellarin R; Gasser G; Tucker JHR; Tanner JA; Savage GP; Hollenstein M
    Chembiochem; 2024 Jan; 25(1):e202300539. PubMed ID: 37837257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic Synthesis of Vancomycin-Modified DNA.
    Figazzolo C; Bonhomme F; Saidjalolov S; Ethève-Quelquejeu M; Hollenstein M
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Aptamers with an Expanded Chemical Repertoire.
    Diafa S; Hollenstein M
    Molecules; 2015 Sep; 20(9):16643-71. PubMed ID: 26389865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into the Processing of Nucleobase-Modified Nucleotides by DNA Polymerases.
    Hottin A; Marx A
    Acc Chem Res; 2016 Mar; 49(3):418-27. PubMed ID: 26947566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customised nucleic acid libraries for enhanced aptamer selection and performance.
    Pfeiffer F; Rosenthal M; Siegl J; Ewers J; Mayer G
    Curr Opin Biotechnol; 2017 Dec; 48():111-118. PubMed ID: 28437710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2'-O,4'-C-methylene-bridged/locked nucleic acid primer.
    Kasahara Y; Irisawa Y; Fujita H; Yahara A; Ozaki H; Obika S; Kuwahara M
    Anal Chem; 2013 May; 85(10):4961-7. PubMed ID: 23662585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primer-free aptamer selection using a random DNA library.
    Pan W; Xin P; Patrick S; Dean S; Keating C; Clawson G
    J Vis Exp; 2010 Jul; (41):. PubMed ID: 20689511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELEX and dynamic combinatorial chemistry interplay for the selection of conjugated RNA aptamers.
    Bugaut A; Toulmé JJ; Rayner B
    Org Biomol Chem; 2006 Nov; 4(22):4082-8. PubMed ID: 17312962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.